AUPO410796A0 - Method of treating benign prostatic hyperplasia - Google Patents
Method of treating benign prostatic hyperplasiaInfo
- Publication number
- AUPO410796A0 AUPO410796A0 AUPO4107A AUPO410796A AUPO410796A0 AU PO410796 A0 AUPO410796 A0 AU PO410796A0 AU PO4107 A AUPO4107 A AU PO4107A AU PO410796 A AUPO410796 A AU PO410796A AU PO410796 A0 AUPO410796 A0 AU PO410796A0
- Authority
- AU
- Australia
- Prior art keywords
- benign prostatic
- prostatic hyperplasia
- treating benign
- treating
- hyperplasia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 title 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 title 1
Priority Applications (16)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPO4107A AUPO410796A0 (en) | 1996-12-06 | 1996-12-06 | Method of treating benign prostatic hyperplasia |
JP51105398A JP3860841B2 (en) | 1996-08-30 | 1997-09-01 | Sustained peptide release formulation |
DK97936524T DK1007080T3 (en) | 1996-08-30 | 1997-09-01 | Formulation for sustained release of peptide agonists and analogues of GnRH |
AT97936524T ATE359805T1 (en) | 1996-08-30 | 1997-09-01 | SUSTAINED RELEASE FORMULATION OF GNRH PEPTIDE AGONISTS AND ANALOGS |
NZ334236A NZ334236A (en) | 1996-08-30 | 1997-09-01 | Composition comprising GnRH, lecithin and stearin |
CA2264562A CA2264562C (en) | 1996-08-30 | 1997-09-01 | Sustained peptide-release formulation |
PCT/AU1997/000560 WO1998008533A1 (en) | 1996-08-30 | 1997-09-01 | Sustained peptide-release formulation |
ES97936524T ES2285737T3 (en) | 1996-08-30 | 1997-09-01 | PROLONGED RELEASE FORM OF GNRH AGEPISTS AND PEPTIDAL ANALOGS. |
AU39345/97A AU713413B2 (en) | 1996-08-30 | 1997-09-01 | Sustained peptide-release formulation |
EP97936524A EP1007080B1 (en) | 1996-08-30 | 1997-09-01 | Formulation for the sustained release of peptide agonists and analogues of GnRH |
DE69737635T DE69737635T2 (en) | 1996-08-30 | 1997-09-01 | Delayed release formulation of peptide agonists and analogs of GnRH |
CN971975485A CN1216636C (en) | 1996-08-30 | 1997-09-01 | Titanium slow-release composition |
US09/242,635 US6337318B1 (en) | 1996-08-30 | 1997-09-01 | Sustained GnRH peptide-release formulation |
HK00101268A HK1022275A1 (en) | 1996-08-30 | 2000-02-29 | Sustained peptide-release formulation. |
US09/991,714 US6777386B2 (en) | 1996-08-30 | 2001-11-26 | Sustained peptide-release formulation |
US10/808,504 US7309689B2 (en) | 1996-08-30 | 2004-03-25 | Sustained peptide-release formulation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPO4107A AUPO410796A0 (en) | 1996-12-06 | 1996-12-06 | Method of treating benign prostatic hyperplasia |
Publications (1)
Publication Number | Publication Date |
---|---|
AUPO410796A0 true AUPO410796A0 (en) | 1997-01-09 |
Family
ID=3798415
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AUPO4107A Abandoned AUPO410796A0 (en) | 1996-08-30 | 1996-12-06 | Method of treating benign prostatic hyperplasia |
Country Status (1)
Country | Link |
---|---|
AU (1) | AUPO410796A0 (en) |
-
1996
- 1996-12-06 AU AUPO4107A patent/AUPO410796A0/en not_active Abandoned
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6393896A (en) | Method for treating benign prostatic hyperplasia with thermal therapy | |
AU6578998A (en) | Method of treatment of migraine | |
AU5173296A (en) | Prostatic tissue expander | |
AU9214398A (en) | Compositions and methods for treating water | |
AU3011299A (en) | Combination therapy for the treatment of benign prostatic hyperplasia | |
AU2235395A (en) | Biological markers of benign prostate hyperplasia | |
AU4518897A (en) | Method of treating atherosclerosis | |
ZA952763B (en) | Use of alpha-1C specific compounds to treat benign prostatic hyperplasia | |
AU9016898A (en) | Methods and compositions for treatment of restenosis | |
AU4003597A (en) | Methods of diagnosing and treating cancer | |
EP0855910A4 (en) | Conjugates useful in the treatment of benign prostatic hyperplasia | |
HU9501286D0 (en) | Methods and compositions of (+) doxazosin for the treatment of benign prostatic hyperplasia and atherosclerosis | |
AU2251897A (en) | Method of treating liver disorders | |
AU9128998A (en) | Composition and method for the treatment of benign prostatic hyperplasia and prostatitis | |
AU6883398A (en) | Methods of treating bone loss | |
EP0633781A4 (en) | Compositions and methods for treating benign prostatic hypertrophy. | |
AU2051397A (en) | Method of treating alopecia | |
AU2337997A (en) | Method of treating cancer using c-26 modified bryostatin | |
AU5457694A (en) | Methods and compositions of (-) doxazosin for the treatment of benign prostatic hyperplasia and atherosclerosis | |
AU2243897A (en) | Methods of treating or preventing pain or nociception | |
AUPO410796A0 (en) | Method of treating benign prostatic hyperplasia | |
AU4027097A (en) | Method of treatment | |
AU4816896A (en) | Treatment and prevention of prostatic cancer | |
AU6172896A (en) | Melatonin agonists for treating benign prostatic hyperplasia | |
AU2002336520A1 (en) | Method of treating benign prostatic hyperplasia and other beingn porstate conditions |